NDC 50488-0901-01 - Laxacin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 50488-0901
Requested NDC: 50488-0901-01
Package NDCs from labels: 50488-0901-1, 50488-0901-01
Manufacturer: Advanced Rx Pharmacy of Tennessee, LLC
Effective date: 2024-12-31
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Laxacin - Advanced Rx Pharmacy of Tennessee, LLC	Advanced Rx Pharmacy of Tennessee, LLC	2024-12-31	HUMAN OTC DRUG LABEL
Laxacin - Alexso, Inc	Alexso, Inc	2024-12-04	HUMAN OTC DRUG LABEL
Laxacin - Quality Care Products, LLC	Quality Care Products, LLC	2023-12-21	HUMAN OTC DRUG LABEL
LAXACIN - Direct_Rx	Direct_Rx	2023-10-06	HUMAN OTC DRUG LABEL
Laxacin Laxative Plus Stool Softener	NuCare Pharmaceuticals,Inc.	2021-02-11	HUMAN OTC DRUG LABEL
Laxacin - medsource pharmaceuticals	medsource pharmaceuticals	2018-12-20	HUMAN OTC DRUG LABEL
LAXACIN - DIRECT RX	DIRECT RX	2018-03-26	HUMAN OTC DRUG LABEL
Laxacin Laxative Plus Stool Softener	Dispensing Solutions, Inc. \| PSS World Medical, Inc.	2013-07-12	HUMAN OTC DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50488-0901-1	Laxacin	100 in 1 BOTTLE	TABLET	100		8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50488-0901	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO, INC]	8	Current NDC, Legacy NDC, 1 package rows	20241208_0df9abaf-3997-4dde-8003-ae3d8d07cf39.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50488-0901-1	EA - Each	50488-0901	933d71c3-b01d-44ff-b256-0bee20827ae8	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
DOCUSATE	ACTIVE MOIETY	M7P27195AG	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
SENNOSIDES A AND B	ACTIVE MOIETY	1B5FPI42EN	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [DISPENSING SOLUTIONS, INC.]	2
DOCUSATE SODIUM	ACTIVE INGREDIENT	F05Q2T2JA0	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
SENNOSIDES A AND B	ACTIVE INGREDIENT	1B5FPI42EN	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
DOCUSATE	ACTIVE MOIETY	M7P27195AG	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
SENNOSIDES	ACTIVE MOIETY	3FYP5M0IJX	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
FD&C YELLOW NO. 6	INACTIVE INGREDIENT	H77VEI93A8	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LAXACIN (DOCUSATE SODIUM AND SENNOSIDES) TABLET [ALEXSO INC]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 89 of 180 · 3,596 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Publix Stimulant Laxative	BISACODYL	PUBLIX SUPER MARKETS, INC	02e596a7-b8e5-4f55-9bc6-6d17e0fabda7	2025-10-28	Warnings	Exact identifier application number: M007
PUBLIX	PSYLLIUM HUSK	PUBLIX SUPER MARKETS, INC	55f98d3f-f282-4f19-b373-0b59640d274d	2025-10-28	Warnings	Exact identifier application number: M007
PUBLIX	CALCIUM POLYCARBOPHIL	PUBLIX SUPER MARKETS, INC	02e3f4ce-8961-425c-98a9-3b9d66709ca5	2025-10-28	Warnings	Exact identifier application number: M007
Publix Women Laxative	BISACODYL	PUBLIX SUPER MARKETS, INC	03eeca55-f239-4a01-a900-c1943f27a834	2025-10-28	Warnings	Exact identifier application number: M007
Publix Fiber Therapy Orange Smooth	PSYLLIUM HUSK	PUBLIX SUPER MARKETS, INC	b9c54c20-cd82-4627-9217-a66834db4799	2025-10-28	Warnings	Exact identifier application number: M007
Publix Fiber Therapy Sugar Free	PSYLLIUM HUSK	PUBLIX SUPER MARKETS, INC	ed3dc80a-a243-4013-9886-b148e3e3b662	2025-10-28	Warnings	Exact identifier application number: M007
Perricone MD Neuropeptide Restorative Neck and Chest Therapy Broad Spectrum SPF 25	TITANIUM DIOXIDE	THG Beauty USA LLC	23f4cf41-0eed-2df3-e063-6294a90ad402	2025-10-28	Warnings	Exact identifier unii: 15FIX9V2JP
TIBENA EVERYTHING MULTI CUSHION SPF50	HOMOSALATE, TITANIUM DIOXIDE	KONAD CO LTD	421eda8f-62b2-30fb-e063-6394a90a4947	2025-10-27	Warnings	Exact identifier unii: 15FIX9V2JP
Childrens Oral Saline Laxative	MAGNESIUM HYDROXIDE	WAL-MART STORES,INC.,	a2eb50ab-851a-4abb-a12f-6d9d8b0cb6bc	2025-10-27	Warnings	Exact identifier application number: M007
equate Fiber Therapy	METHYLCELLULOSE	Wal-Mart Stores,Inc.,	7acc30b4-e946-42cd-8eec-cf15159d478d	2025-10-27	Warnings	Exact identifier application number: M007
Anti Nausea	DEXTROSE(GLUCOSE),LEVULOSE(FRUCTOSE),PHOSPHORIC ACID	RUGBY LABORATORIES	8506b4ab-a19e-4b0d-aa98-143bf75a1171	2025-10-25	Warnings	Exact identifier unii: IY9XDZ35W2
Glycerin	GLYCERIN	DSC Laboratories Inc.	5e97aa5b-62e2-0664-e053-2a91aa0ac341	2025-10-24	Warnings	Exact identifier application number: M007
Glycerin	GLYCERIN	H E B	3d03ce42-e671-6d76-e054-00144ff8d46c	2025-10-24	Warnings	Exact identifier application number: M007
Bisacodyl	BISACODYL	CVS Pharmacy	c56e010a-7503-3e1c-e053-2a95a90a2b85	2025-10-24	Warnings	Exact identifier application number: M007
Glycerin	GLYCERIN	Chain Drug Consortium LLC	022dd494-cb3c-4fa7-be99-4c38fabdc612	2025-10-24	Warnings	Exact identifier application number: M007
Glycerin	GLYCERIN	DSC Laboratories Inc.	5e97c4d2-e41d-5bb6-e053-2a91aa0a3163	2025-10-24	Warnings	Exact identifier application number: M007
Bisacodyl	BISACODYL	Major Pharmaceuticals	c194c40c-c732-2f03-e053-2a95a90a7a40	2025-10-24	Warnings	Exact identifier application number: M007
Glycerin	GLYCERIN	CVS Pharmacy	94e4a6f3-43d0-b2a5-e053-2a95a90aa115	2025-10-24	Warnings	Exact identifier application number: M007
Glycerin	GLYCERIN	Chain Drug Marketing Association Inc.	5e83d3ef-91c5-1c3a-e053-2a91aa0a93ed	2025-10-24	Warnings	Exact identifier application number: M007
Glycerin	GLYCERIN	Rite Aid Corporation	5da2ea79-f3bc-b82b-e053-2a91aa0af0af	2025-10-24	Warnings	Exact identifier application number: M007

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.